Literature DB >> 2676479

Evidence for heterogeneity of the osteoblastic phenotype determined with clonal rat bone cells established from transforming growth factor-beta-induced cell colonies grown anchorage independently in semisolid medium.

H L Guenther1, W Hofstetter, A Stutzer, R Mühlbauer, H Fleisch.   

Abstract

Numerous reports have appeared in the literature indicating phenotypic heterogeneity among cells of the osteoblastic lineage. This diversity may be due to either certain stages of differentiation or a subspecialization of already terminally differentiated osteoblasts. To obtain answers to this question, we report on studies undertaken to clone bone cell populations from 1 day postnatal rat calvaria which express well defined differences in phenotype. To achieve this goal, we have used the soft agarose cloning technique which previously has almost exclusively been applied to clone cells of neoplastic origin. The reason for being able to employ this method is based on the fact that bone cells can be induced by transforming growth factor-beta to reversibly acquire the transformed phenotype, an event expressed by anchorage-dependent bone cells to form progressively growing colonies in soft agarose. Individual colonies, harvested from agarose, were expanded to clonal bone cell populations. Characterizing 48 cell clones by detection of osteoblastic cell markers such as alkaline phosphatase activity, PTH- and prostaglandin-E2-induced adenylate cyclase activity, osteocalcin mRNA synthesis, as well as collagen synthesis, 7 subsets of osteoblastic cell types were identified. Each subset was found to express a distinct phenotype, indicated by the absence or presence of osteoblastic cell markers. Some clones, previously found not to exhibit any osteoblastic traits, developed PTH responsiveness when treated with insulin-like growth factor-I/transforming growth factor-beta, suggesting that these clones may originate from the osteoprogenitor cell pool. While most clonal cell populations were characterized as fully functional osteoblastic cells, some clones expressed merely 1, 2, or 3 osteoblastic markers, which suggests that they may represent stages of differentiation along the osteogenic pathway. In addition, other subclones displayed the capacity to synthesize osteocalcin and showed PTH and prostaglandin-E2 responsiveness, but were found to be devoid of alkaline phosphatase activity. Others expressed all osteoblastic cell markers except PTH responsiveness. The phenotypic constellation of the latter suggests that these cell clones may represent mature osteoblast-like cells, which, perhaps due to environmental circumstances present at the time of isolation, have become altered in accordance with the physiological requirements of the tissue.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2676479     DOI: 10.1210/endo-125-4-2092

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  15 in total

1.  Clonal osteogenic cell lines express myogenic and adipocytic developmental potential.

Authors:  A Yamaguchi; A J Kahn
Journal:  Calcif Tissue Int       Date:  1991-09       Impact factor: 4.333

2.  The procalcitonin amino-terminal cleavage peptide (N-proCT) lacks biological activity on normal clonal rat osteoblastic and preosteoblastic cells in vitro.

Authors:  H L Guenther; H Fleisch
Journal:  Calcif Tissue Int       Date:  1991-08       Impact factor: 4.333

3.  Establishment of an osteogenic cell line derived from adult mouse bone marrow stroma by use of a recombinant retrovirus.

Authors:  E Mathieu; G Schoeters; F vander Plaetse; J Merregaert
Journal:  Calcif Tissue Int       Date:  1992-04       Impact factor: 4.333

4.  Differential depolarization-activated calcium responses in fetal and neonatal rat osteoblast-like cells.

Authors:  A Wiltink; B Van Duijn; A F Weidema; A De Vos; J M van der Meer; P J Nijweide; D L Ypey
Journal:  Calcif Tissue Int       Date:  1994-04       Impact factor: 4.333

5.  TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify.

Authors:  K E Watson; K Boström; R Ravindranath; T Lam; B Norton; L L Demer
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

6.  Bisphosphonates act on rat bone resorption through the mediation of osteoblasts.

Authors:  M Sahni; H L Guenther; H Fleisch; P Collin; T J Martin
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

7.  Measurement of intracellular Ca2+ in single aequorin-injected and suspensions of fura-2-loaded ROS 17/2.8 cells and normal human osteoblasts. Effect of parathyroid hormone.

Authors:  C Schöfl; K S Cuthbertson; J A Gallagher; S R Pennington; P H Cobbold; G Brabant; R D Hesch; A von zur Mühlen
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

Review 8.  Control of RANKL gene expression.

Authors:  Charles A O'Brien
Journal:  Bone       Date:  2009-08-27       Impact factor: 4.398

9.  Expression of collagen, osteocalcin, and bone alkaline phosphatase in a mineralizing rat osteoblastic cell culture.

Authors:  P Collin; J R Nefussi; A Wetterwald; V Nicolas; M L Boy-Lefevre; H Fleisch; N Forest
Journal:  Calcif Tissue Int       Date:  1992-02       Impact factor: 4.333

10.  Expression of selected osteogenic markers in the fibroblast-like cells of rat marrow stroma.

Authors:  R W Zhang; S C Supowit; X Xu; H Li; M D Christensen; R Lozano; D J Simmons
Journal:  Calcif Tissue Int       Date:  1995-04       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.